Correction for Verma et al., Circulation 108 (6) 736-740.

This Article Extract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

(Circulation. 2004;109:2254.)
© 2004 American Heart Association, Inc.

Correction

In the article, "Resistin Promotes Endothelial Cell Activation: Further Evidence of Adipokine-Endothelial Interaction" by Verma et al, which first appeared online as a Rapid Track (Circulation. 2003;108:r24–r28) and subsequently printed in the August 12, 2003, issue of the journal (Circulation. 2003;108:736–740), the source of human recombinant resistin was incorrect. On page 2 of the Rapid Track version and page 737 of the print version, under the heading Cell Culture, in the sentence, "HSVECs at passages 2 through 5 were incubated with purified human recombinant resistin (Phoenix Pharmaceuticals, Inc) for 24 hours at 10, 50, and 100 ng/mL, respectively," "Phoenix Pharmaceuticals, Inc" should be "Novus Biological."

This Article Extract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content